Evidence map›Paper›PMID 33611864›Full record

ArticleCancer medicine2021

An immature inhibin-α-expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis.

Shinya Kusumoto, Masako Kurashige, Kenji Ohshima, Shinichiro Tahara, Takahiro Matsui, Satoshi Nojima, Satoshi Hattori, Eiichi Morii

Open access · goldAbstract read
In one paragraph

Article in Cancer medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Evolving roles of activins and inhibins in ovarian cancer pathophysiology.American journal of physiology. Cell physiology · 2023
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shinya KusumotoDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-4551-6719
Masako KurashigeDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
Kenji OhshimaDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0003-1114-386X
Shinichiro TaharaDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0001-6134-3275
Takahiro MatsuiDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.
Satoshi NojimaDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0002-5124-0026
Satoshi HattoriDivision of Biomedical Statistics, Department of Integrated Medicine, Graduate School of Medicine, and Institute for Open and Transdisciplinary Research Initiatives, Osaka University, Osaka, Japan.
Eiichi MoriiDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan.ORCID 0000-0001-8490-3650
The University of Osaka · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inhibin-α, a member of transforming growth factor-β, is elevated in multiple tumors, but its specific roles are poorly understood. Here, we examined the feature of inhibin-α-expressing cells in ovarian tumors. Immunohistochemically, inhibin-α-expressing tumor cells were detected only in ovarian clear cell carcinoma (OCCC) among various types of ovarian tumors. By comparing the expression of inhibin-α and Ki-67, inhibin-α-expressing tumor cells were revealed to be less proliferative. When spheroids and chemoresistant cells were derived from OCCC cell lines, the expression level of inhibin-α was elevated, and that of an immature marker, aldehyde dehydrogenase, was also elevated. In consistent with this, inhibin-α expression was correlated with other immature markers, such as OCT3/4 and SOX2, and inversely correlated with proliferative marker MKI67 in public database on OCCC. Knockdown of inhibin-α in OCCC cell decreased chemoresistance. Moreover, prognostic analysis with 69 surgically resected OCCC cases revealed that the increased inhibin-α expression was an independent unfavorable prognostic factor. These findings suggested that inhibin-α-expressing subpopulation of OCCC tumor cells appeared to be less proliferative, immature, and angiogenic and to be related to acceleration of malignant progression.

Indexed as

Adenocarcinoma, Clear CellAldehyde DehydrogenaseCell Line, TumorCell ProliferationDisease ProgressionDrug Resistance, NeoplasmFemaleGene SilencingHumansInhibinsKi-67 AntigenMiddle AgedNeoplasm ProteinsOctamer Transcription Factor-3Ovarian NeoplasmsPrognosisAldehyde Dehydrogenaseinhibin-alpha subunitInhibinsKi-67 AntigenMKI67 protein, humanNeoplasm ProteinsOctamer Transcription Factor-3POU5F1 protein, humanSOX2 protein, humanSOXB1 Transcription FactorsVascular Endothelial Growth Factor AVascular Endothelial Growth Factor CVEGFA protein, human

Identifiers

PMID33611864
PMCPMC7940216
OpenAlexW3129837312

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.